Dose response and pharmacokinetics of tofacitinib (CP-690,550), an oral janus kinase inhibitor, in the treatment of chronic plaque psoriasis

H. Tan; P. Gupta; J. Harness; R. Wolk; S. Chapel; A. Menter; B. Strober; R. G. Langley; S. Krishnaswami; K. A. Papp

doi:10.1038/psp.2013.22

Dose response and pharmacokinetics of tofacitinib (CP-690,550), an oral janus kinase inhibitor, in the treatment of chronic plaque psoriasis

H. Tan, P. Gupta, J. Harness, R. Wolk, S. Chapel, A. Menter, B. Strober, R. G. Langley, S. Krishnaswami, K. A. Papp

Inernational Relations Division

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Original language	English
Article number	e44
Journal	CPT: Pharmacometrics and Systems Pharmacology
Volume	2
Issue number	5
DOIs	https://doi.org/10.1038/psp.2013.22
Publication status	Published - May 2013

ASJC Scopus Subject Areas

Modelling and Simulation
Pharmacology (medical)

Access to Document

10.1038/psp.2013.22

Cite this

Tan, H., Gupta, P., Harness, J., Wolk, R., Chapel, S., Menter, A., Strober, B., Langley, R. G., Krishnaswami, S., & Papp, K. A. (2013). Dose response and pharmacokinetics of tofacitinib (CP-690,550), an oral janus kinase inhibitor, in the treatment of chronic plaque psoriasis. CPT: Pharmacometrics and Systems Pharmacology, 2(5), Article e44. https://doi.org/10.1038/psp.2013.22

@article{7f16ae78693c43a4b0b662bf46e73112,

title = "Dose response and pharmacokinetics of tofacitinib (CP-690,550), an oral janus kinase inhibitor, in the treatment of chronic plaque psoriasis",

author = "H. Tan and P. Gupta and J. Harness and R. Wolk and S. Chapel and A. Menter and B. Strober and Langley, {R. G.} and S. Krishnaswami and Papp, {K. A.}",

year = "2013",

month = may,

doi = "10.1038/psp.2013.22",

language = "English",

volume = "2",

journal = "CPT: Pharmacometrics and Systems Pharmacology",

issn = "2163-8306",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Dose response and pharmacokinetics of tofacitinib (CP-690,550), an oral janus kinase inhibitor, in the treatment of chronic plaque psoriasis

AU - Tan, H.

AU - Gupta, P.

AU - Harness, J.

AU - Wolk, R.

AU - Chapel, S.

AU - Menter, A.

AU - Strober, B.

AU - Langley, R. G.

AU - Krishnaswami, S.

AU - Papp, K. A.

PY - 2013/5

Y1 - 2013/5

UR - http://www.scopus.com/inward/record.url?scp=84881183888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881183888&partnerID=8YFLogxK

U2 - 10.1038/psp.2013.22

DO - 10.1038/psp.2013.22

M3 - Article

AN - SCOPUS:84881183888

SN - 2163-8306

VL - 2

JO - CPT: Pharmacometrics and Systems Pharmacology

JF - CPT: Pharmacometrics and Systems Pharmacology

IS - 5

M1 - e44

ER -

Dose response and pharmacokinetics of tofacitinib (CP-690,550), an oral janus kinase inhibitor, in the treatment of chronic plaque psoriasis

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this